Daunomycin in the treatment of metastatic soft tissue sarcoma in children.
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003630:Daunorubicin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D005260:Female; D005354:Fibrosarcoma / Q000188:drug therapy; D006394:Hemangiosarcoma / Q000188:drug therapy; D006801:Humans; D007890:Leiomyosarcoma / Q000188:drug therapy; D007970:Leukopenia / Q000139:chemically induced; D008080:Liposarcoma / Q000188:drug therapy; D008297:Male; D009362:Neoplasm Metastasis; D012208:Rhabdomyosarcoma / Q000188:drug therapy*; D012509:Sarcoma / Q000188:drug therapy*; D013921:Thrombocytopenia / Q000139:chemically induced
D003630:Daunorubicin